Mary’s Medicinals is a nutraceutical company, innovating at the intersection of engineering and horticulture. Mary’s is a company focused on transforming how people view and utilize cannabis, developing products that isolate the benefits of cannabis and other vital plant extracts for optimum patient care. There are an estimated 80+ cannabinoids found in cannabis, each containing a unique neuropathic effect and the company’s patent pending transdermal patch offers a cost effective, accurate and clean delivery of these unique compounds.
Mary's Medicinals aims to establish a global brand of medicinal products; catering to patients who want to use cannabis as a nutraceutical alternative to traditional or prescription medications, while educating patients and the public on plant derived medicinal products.
With the launch of its inaugural product, the transdermal patch, Mary's offers a variety of choices for both THC and non THC cannabis users to medicate in an accurately dosed, discreet use, clean delivery method.
Mary's currently offers THC, THCa, CBN, CBD and 1:1 CBD/THC transdermal patches all in 10mg dosing.